https://medicaldialogues.in/cardiology-ctvs/news/are-non-vitamin-k-oral-anticoagulants-feasible-for-patients-with-atrial-fibrillation-on-hemodialysis-103165
0
0
12/4/22 at 2:30pm
Organization
Medical Dialogues
Author
Medha Baranwal
44 words
0
Comments
Germany: A recent study comparing apixaban and vitamin K antagonist (VKA) in atrial fibrillation (AF) patients on hemodialysis revealed no differences in safety or efficacy outcomes. AF patients
You are the first to view
Create an account
or login to join the discussion